Permanent HCPCS code granted following U.S. FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ Direct Visualization System (DVS), together referred to as LumiSystem™, with commercial ...

The application of this code will not result in additional payment for a billed E/M visit service. A version of this article was first published February 8, 2021, by HCPro's Revenue Cycle Advisor, a ...

On Oct. 31, CMS released the HCPCS Level II codes that go into effect Jan. 1, 2012, a set that includes 285 code additions, 48 revisions and 75 deletions compared to the previous version, according to ...

DENVER, March 26, 2025--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. ("TriSalus" or the "Company") (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our ...

FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and ...

-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) -- -- Proceeds from recent stock issuances ...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”, NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address ...

BOSTON & LONDON — Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, welcomes the recent announcement by the Centers for Medicare & Medicaid ...

Maxiocel, Advamedica’s chitosan-based wound care dressing, gets USFDA 510(k) clearance & HCPCS codes, boosting US access for chronic & acute wound treatment. MaxioCel is a soft, sterile, single-use ...

NEWTOWN, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...